Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vacasa, Inc. - Class A Common Stock (NQ: VCSA )

3.680 -0.260 (-6.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vacasa, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Vacasa Announces Reverse Stock Split
From Vacasa
Via Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Vacasa Announces Second Quarter 2023 Financial Results
From Vacasa
Via Business Wire
Vacasa, Inc. (NASDAQ:VCSA) Shareholder Notice: Investigation Announced over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 07/31/2023 -- An investigation announced over potential breaches of fiduciary duties by certain officers and directors at Vacasa, Inc. 
Via SBWire
The Latest Analyst Ratings for Vacasa
Via Benzinga
Analyst Ratings for Vacasa
Via Benzinga
Vacasa to Announce Second Quarter 2023 Financial Results on August 8, 2023
From Vacasa
Via Business Wire
Alibaba Shakes Things Up
Alibaba shuffles the deck as it heads toward spinning off its cloud division. 
Via The Motley Fool
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
Via Benzinga
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 479 stocks made new 52-week lows. 
Via Benzinga
JMP Securities Maintains Market Outperform Rating for Vacasa: Here's What You Need To Know
Via Benzinga
4 Analysts Have This to Say About Vacasa
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
7 High-Growth Tech Stocks to Buy to Become a Millionaire
Although these enterprises are terribly risky, for the daring, they could turn out to be millionaire-maker tech stocks to buy. 
Via InvestorPlace
Vacasa Announces First Quarter 2023 Financial Results
From Vacasa
Via Business Wire
Vacasa Appoints Bruce Schuman as New Chief Financial Officer
From Vacasa
Via Business Wire
Earnings Scheduled For May 9, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga
Vacasa to Announce First Quarter 2023 Financial Results on May 9, 2023
From Vacasa
Via Business Wire
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Via Benzinga
Vacasa Announces New Board Nominee
From Vacasa
Via Business Wire
Vacasa Releases its 2023 Best Places to Buy a Beach House Report
From Vacasa
Via Business Wire
NASDAQ:VCSA Investor Notice: Investigation over Possible Securities Laws Violations by Vacasa, Inc.
San Diego, CA -- (SBWIRE) -- 03/22/2023 -- An investigation was announced for investors of Vacasa, Inc. (NASDAQ:VCSA) shares over potential securities laws violations by Vacasa, Inc. f.k.a. TPG Pace... 
Via SBWire
This Analyst With 86% Accuracy Rate Sees Around 240% Upside In Vacasa - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes... 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
Via Benzinga
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.